High Katherine A
SEC CIK 1631248 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | Dir | 15.0K | — | — | 5 | 2022-06-15 | 2026-06-08 |
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
| 15 | High Katherine A | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 16:05 | 2026-06-08 | INCY | Incyte | High Katherine A | Dir | A - Grant | $0.00 | +1,642 | 15.0K | +12% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | Incyte | High Katherine A | Dir | A - Grant | $0.00 | +2,518 | 13.3K | +23% | $0 |
| D | 2024-06-14 | 2024-06-12 | INCY | Incyte | High Katherine A | Dir | A - Grant | $0.00 | +2,830 | 10.8K | +35% | $0 |
| D | 2023-06-16 | 2023-06-14 | INCY | Incyte | High Katherine A | Dir | A - Grant | $0.00 | +2,505 | 7,993 | +46% | $0 |
| D | 2022-06-17 | 2022-06-15 | INCY | Incyte | High Katherine A | Dir | A - Grant | $0.00 | +2,144 | 5,488 | +64% | $0 |
Purchase Sale Sale after option exercise All abbreviations